Literature DB >> 28178263

Novartis snaps up Selexys for sickle cell.

Chris Morrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28178263     DOI: 10.1038/nbt0217-106

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Biogen and UPenn join forces to commercialize gene therapies.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2016-08-09       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.